Yvonne Denier
Overview
Explore the profile of Yvonne Denier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
410
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Howes J, Denier Y, Gastmans C
Am J Bioeth
. 2025 Jan;
25(2):153-156.
PMID: 39878713
No abstract available.
2.
Coremans R, Saerens A, De Lepeleire J, Denier Y
PLoS One
. 2024 Aug;
19(8):e0306026.
PMID: 39213329
Background: Moral distress in and ethical climate of health care institutions are highly intertwined subjects and have been linked to various quality of care indicators as well as job turnover...
3.
Boons L, Jeandarme I, Denier Y
Arch Sex Behav
. 2024 Jun;
53(7):2509-2527.
PMID: 38902489
Forensic inpatients reside for long periods in restricted environments, which do not support the presence of sexual experiences or the expression of existing needs. However, sexuality and sexual health are...
4.
Howes J, Denier Y, Vandemeulebroucke T, Gastmans C
Sci Eng Ethics
. 2024 May;
30(3):17.
PMID: 38720094
Wandering is a symptom of dementia that can have devastating consequences on the lives of persons living with dementia and their families and caregivers. Increasingly, caregivers are turning towards electronic...
5.
6.
Howes J, Denier Y, Gastmans C
JMIR Aging
. 2022 Nov;
5(4):e38865.
PMID: 36367765
Background: Electronic tracking devices, also known as locators, monitors, or surveillance devices, are increasingly being used to manage dementia-related wandering and, subsequently, raising various ethical questions. Despite the known importance...
7.
Blonda A, Denier Y, Huys I, Kawalec P, Simoens S
Front Pharmacol
. 2022 Aug;
13:902150.
PMID: 35928274
The expansion of orphan drug treatment at increasing prices, together with uncertainties regarding their (cost-)effectiveness raises difficulties for decision-makers to assess these drugs for reimbursement. The present qualitative study aims...
8.
Vandemeulebroucke T, Denier Y, Mertens E, Gastmans C
Sci Eng Ethics
. 2022 May;
28(3):26.
PMID: 35639210
Innovations permeate healthcare settings on an ever-increasing scale. Health technology innovations (HTIs) impact our perceptions and experiences of health, care, disease, etc. Because of the fast pace these HTIs are...
9.
Vandemeulebroucke T, Denier Y, Gastmans C
Am J Bioeth
. 2022 Apr;
22(5):33-35.
PMID: 35475955
No abstract available.
10.
Blonda A, Denier Y, Huys I, Simoens S
Front Pharmacol
. 2021 May;
12:631527.
PMID: 34054519
Decision-makers have implemented a variety of value assessment frameworks (VAFs) for orphan drugs in European jurisdictions, which has contributed to variations in access for rare disease patients. This review provides...